These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 26919356

  • 1. Topical psoriasis therapies and unmet patient needs: the importance of optimizing methotrexate.
    Greenberg R.
    Cutis; 2016 Jan; 97(1):55-6. PubMed ID: 26919356
    [No Abstract] [Full Text] [Related]

  • 2. Childhood generalized pustular psoriasis: longtime remission with combined infliximab and methotrexate treatment.
    Skrabl-Baumgartner A, Weger W, Salmhofer W, Jahnel J.
    Pediatr Dermatol; 2015 Jan; 32(1):e13-4. PubMed ID: 25644044
    [Abstract] [Full Text] [Related]

  • 3. The use of self-administered subcutaneous methotrexate for the treatment of psoriasis.
    Chiaravalloti AJ, Strober BE.
    J Drugs Dermatol; 2014 Aug; 13(8):929-31. PubMed ID: 25116970
    [Abstract] [Full Text] [Related]

  • 4. Effective management of psoriasis symptom worsening during efalizumab therapy without discontinuing treatment: a case study.
    Gisondi P, Giglio MD, Girolomoni G.
    J Dermatolog Treat; 2006 Aug; 17(3):172-5. PubMed ID: 16854760
    [Abstract] [Full Text] [Related]

  • 5. The METOP Study: Further Evidence for the Use of Subcutaneous Methotrexate in Psoriasis.
    Morgado-Carrasco D, Fustà-Novell X, Riera Monroig J, Mascaró Galy JM.
    Actas Dermosifiliogr; 2017 Nov; 108(9):865-866. PubMed ID: 28583269
    [No Abstract] [Full Text] [Related]

  • 6. Psoriasis of the lips: an unusual localization.
    Gül U, Kiliç A, Gönül M, Soylu S, Bilgili S, Han O.
    Int J Dermatol; 2006 Nov; 45(11):1381-2. PubMed ID: 17076738
    [No Abstract] [Full Text] [Related]

  • 7. Nail psoriasis successfully treated with intralesional methotrexate: case report.
    Sarıcaoglu H, Oz A, Turan H.
    Dermatology; 2011 Feb; 222(1):5-7. PubMed ID: 21228554
    [Abstract] [Full Text] [Related]

  • 8. Treatment of psoriasis. Part 2. Systemic therapies.
    Lebwohl M, Ali S.
    J Am Acad Dermatol; 2001 Nov; 45(5):649-61; quiz 662-4. PubMed ID: 11606913
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate in psoriasis: consensus conference.
    Roenigk HH, Auerbach R, Maibach H, Weinstein G, Lebwohl M.
    J Am Acad Dermatol; 1998 Mar; 38(3):478-85. PubMed ID: 9520032
    [No Abstract] [Full Text] [Related]

  • 10. Combination therapy of biologics with traditional agents in psoriasis.
    Guenther LC.
    Skin Therapy Lett; 2011 Jun; 16(6):1-3. PubMed ID: 21833461
    [Abstract] [Full Text] [Related]

  • 11. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M.
    Arch Dermatol; 2004 Mar; 140(3):347-8. PubMed ID: 15023778
    [No Abstract] [Full Text] [Related]

  • 12. Intermittent, short term use of methotrexate for exacerbations of psoriasis.
    Clark AR, Feldman SR.
    Int J Dermatol; 1997 Dec; 36(12):954-5. PubMed ID: 9466209
    [No Abstract] [Full Text] [Related]

  • 13. [Current status of the treatment of psoriasis?].
    Touraine R.
    Rev Prat; 1974 Apr 21; 24(23):2141-4, 2147-8. PubMed ID: 4416969
    [No Abstract] [Full Text] [Related]

  • 14. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
    Eskicirak B, Zemheri E, Cerkezoglu A.
    Int J Dermatol; 2006 Aug 21; 45(8):965-9. PubMed ID: 16911386
    [Abstract] [Full Text] [Related]

  • 15. Methotrexate and psoriasis in the era of new biologic agents.
    Saporito FC, Menter MA.
    J Am Acad Dermatol; 2004 Feb 21; 50(2):301-9. PubMed ID: 14726893
    [No Abstract] [Full Text] [Related]

  • 16. Psoriasis: the new and the old.
    Feldman SR.
    J Drugs Dermatol; 2014 Aug 21; 13(8):894. PubMed ID: 25116962
    [No Abstract] [Full Text] [Related]

  • 17. Clearance in psoriasis treatment.
    Kumar B, Saraswat A.
    J Am Acad Dermatol; 2001 Jul 21; 45(1):153-4. PubMed ID: 11423858
    [No Abstract] [Full Text] [Related]

  • 18. Palmoplantar pustular psoriasis following initiation of a beta-blocker: disease control with low-dose methotrexate.
    Stanford CW, Kollipara R, Melookaran AM, Hall JC.
    Cutis; 2014 Sep 21; 94(3):153-5. PubMed ID: 25279477
    [Abstract] [Full Text] [Related]

  • 19. Vitamin D and systemic therapy.
    van de Kerkhof P.
    Cutis; 2002 Nov 21; 70(5 Suppl):16-20. PubMed ID: 12467335
    [Abstract] [Full Text] [Related]

  • 20. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
    Katz HI.
    J Am Acad Dermatol; 1997 Sep 21; 37(3 Pt 2):S62-8. PubMed ID: 9344188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.